Skip to main content
TipRanks
Go Ultimate75% OFF

Universe Pharmaceuticals (UPC) Stock Statistics & Valuation Metrics

228 Followers

Total Valuation

Universe Pharmaceuticals has a market cap or net worth of $7.84M. The enterprise value is -$17.95M.

Market Cap
$7.84M
Enterprise Value
-$17.95M

Share Statistics

Universe Pharmaceuticals has 5,008,313 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
5,008,313
Owned by Insiders
0.32%
Owned by Institutions
0.94%

Financial Efficiency

Universe Pharmaceuticals’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -4.46%.

Return on Equity (ROE)
-0.07
Return on Assets (ROA)
-0.05
Return on Invested Capital (ROIC)
-4.46%
Return on Capital Employed (ROCE)
-0.05
Revenue Per Employee
82.68K
Profits Per Employee
-17.00K
Employee Count
216
Asset Turnover
0.26
Inventory Turnover
5.27

Valuation Ratios

The current PE Ratio of Universe Pharmaceuticals is -0.41. Universe Pharmaceuticals’s PEG ratio is 0.00.

PE Ratio
-0.41
PS Ratio
0.05
PB Ratio
0.01
Price to FCF
-0.07
Price to Operating Cash Flow
-0.07
PEG Ratio
0.00

Income Statement

In the last 12 months, Universe Pharmaceuticals had revenue of 17.86M and earned -3.67M in profits. Earnings per share was -1055.75.

Revenue
17.86M
Gross Profit
6.30M
Operating Income
-2.92M
Pretax Income
-3.67M
Net Income
-3.67M
EBITDA
-2.92M
Earnings Per Share (EPS)
-1055.75

Cash Flow

In the last 12 months, operating cash flow was -11.91M and capital expenditures -481,018, giving a free cash flow of -12.39M billion.

Operating Cash Flow
-11.91M
Free Cash Flow
-12.39M
Free Cash Flow per Share
-22.00

Dividends & Yields

Universe Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-1325.42%
Earnings Yield
-232.94%

Stock Price Statistics

Beta
3.44
52-Week Price Change
-57.26%
50-Day Moving Average
3.54
200-Day Moving Average
3.67
Relative Strength Index (RSI)
29.32
Average Volume (3m)
151.78K

Important Dates

Universe Pharmaceuticals upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date
Aug 03, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Universe Pharmaceuticals as a current ratio of 4.07, with Debt / Equity ratio of 16.49%

Current Ratio
4.07
Quick Ratio
3.90
Debt to Market Cap
633.71
Net Debt to EBITDA
8.33
Interest Coverage Ratio
-12.57

Taxes

In the past 12 months, Universe Pharmaceuticals has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Universe Pharmaceuticals EV to EBITDA ratio is 13.08, with an EV/FCF ratio of 1.38.

EV to Sales
-0.96
EV to EBITDA
13.08
EV to Free Cash Flow
1.38
EV to Operating Cash Flow
1.43

Balance Sheet

Universe Pharmaceuticals has $29.05M in cash and marketable securities with $9.55M in debt, giving a net cash position of $19.50M billion.

Cash & Marketable Securities
$29.05M
Total Debt
$9.55M
Net Cash
$19.50M
Net Cash Per Share
$3.89
Tangible Book Value Per Share
$98.23

Margins

Gross margin is 35.86%, with operating margin of -11.78%, and net profit margin of -10.95%.

Gross Margin
35.86%
Operating Margin
-11.78%
Pretax Margin
-10.95%
Net Profit Margin
-10.95%
EBITDA Margin
-7.36%
EBIT Margin
-10.06%

Analyst Forecast

The average price target for Universe Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-8.04%
EPS Growth Forecast
-100.01%

Scores

Smart Score
―
AI Score
41